More Remdesivir Data, More Questions Linger

Coronavirus
Clinicians have some clues about the best patients for remdesivir, but say more information still is needed after studies were published. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D